BACKGROUND Sodium-glucose cotransporter 2(SGLT2)inhibitors are widely used for the tr-eatment of type 2 diabetes(T2D).AIM To evaluate the influence of SGLT2 inhibitors on homeostasis model assessment of insulin resist...BACKGROUND Sodium-glucose cotransporter 2(SGLT2)inhibitors are widely used for the tr-eatment of type 2 diabetes(T2D).AIM To evaluate the influence of SGLT2 inhibitors on homeostasis model assessment of insulin resistance(HOMA-IR)andβ-cell function(HOMA-β)in patients with T2D in a meta-analysis.METHODS Randomized controlled trials(RCTs)comparing SGLT2 inhibitors to placebo in T2D patients,with a minimum treatment duration of 12 weeks,were searched using the PubMed,EMBASE,and Cochrane Library databases.Risk of bias was assessed using the Cochrane Risk of Bias Tool,and the certainty of evidence was evaluated using the Grading of Recommendations,Assessment,Development and Evaluation(GRADE)system.Changes in HOMA-IR and HOMA-βwere the outcomes analyzed.Meta-analyses were performed using a random-effects model by incorporating the potential influences of heterogeneity.RESULTS Of 1388 articles identified,24 RCTs met the inclusion criteria.23 of the included studies were double-blind RCTs with low risk of bias.Pooled results including 2272 patients showed that SGLT2 inhibitors significantly reduced HOMA-IR compared to placebo[mean difference(MD)=-0.81,95%confidence interval(CI):-1.11 to-0.52,P<0.001;I2=82%],indicating reduced insulin resistance.Addi-tionally,meta-analysis with 2845 patients suggested that SGLT2 inhibitors significantly increased HOMA-β(MD=7.90,95%CI:5.44-10.37,P<0.001;I2=74%)compared to placebo in patients with T2D,indicating improvedβ-cell function.Based on GRADE assessment,the certainty of evidence was rated moderate for both outcomes due to heterogeneity.Subgroup analyses showed that HOMA-βincreased more substantially in non-Asian studies than in Asian studies(P for subgroup difference<0.01).Subgroup analyses according to the individual medications of SGLT2 inhibitors all showed significant improvement of HOMA-IR and HOMA-β(P all<0.05).No significant publication bias was detected(P for Egger’s test all>0.05).CONCLUSION SGLT2 inhibitors are associated with improvements in insulin resistance andβ-cell function in patients with T2D,although the certainty of evidence is moderate due to heterogeneity.展开更多
Balancing high display performance with energy efficiency is crucial for global sustainability.Lowering operating frequencies—such as enabling 1 Hz operation in fringe-field switching(FFS)liquid crystal displays—red...Balancing high display performance with energy efficiency is crucial for global sustainability.Lowering operating frequencies—such as enabling 1 Hz operation in fringe-field switching(FFS)liquid crystal displays—reduces power consumption but is hindered by image flicker.While negative dielectric anisotropy liquid crystals(nLCs)mitigate flicker,their high driving voltages and production costs limit adoption.Positive dielectric anisotropy liquid crystals(pLCs)offer lower operating voltages,faster response times,and broader applicability,making them a more viable alternative.This study introduces a novel approach to minimizing flexoelectric effects in pLCs by investigating how single components influence flexoelectric behavior in mixtures through an effective experimental methodology.Two innovative measurement techniques—(1)flexoelectric coefficient difference analysis and(2)displacement-current measurement(DCM)—are presented,marking the first application of DCM for verifying flexoelectric effects.The proposed system eliminates uncertainties associated with previous methods,providing a reliable framework for selecting liquid crystal components with minimal flexoelectric effects while preserving key electro-optic properties.Given pLCs'higher reliability,lower production costs,and broader material selection,these advancements hold significant potential for low-power displays.We believe this work enhances flexoelectric analysis in nematic liquid crystals and contributes to sustainable innovation in the display industry,aligning with global energy-saving goals.展开更多
本文系统阐述了经口吸入和鼻用药物制剂(orally inhaled and nasal drug products,OINDPs)生物等效性(bioequivalence,BE)研究评估背景,综述了中国及国际上对该类制剂生物等效性的要求及体外等效性评价指导原则,详细阐述了美国食品药品...本文系统阐述了经口吸入和鼻用药物制剂(orally inhaled and nasal drug products,OINDPs)生物等效性(bioequivalence,BE)研究评估背景,综述了中国及国际上对该类制剂生物等效性的要求及体外等效性评价指导原则,详细阐述了美国食品药品管理局(FDA)体外生物等效性(in vitro bioequivalence,IVBE)评估的统计学方法和计算公式。采用FDA颁布的布地奈德吸入混悬液指导原则拟定稿中的实例,通过R语言编程途径计算群体生物等效性(population bioequivalence,PBE)统计学参数,并将结果与指导原则中的结果进行对比,提供计算程序的伪代码。本文为OINDPs的研发、质量控制及仿制制剂的开发提供了有益的思路与参考。展开更多
自胡椒科胡椒属植物樟叶胡椒(Piper polysyphorum C. DC)中分离到六个新木脂素(neolignans)类化合物,经光谱(UV,IR,MS,~1H-NMR,^(13)C-NMR,2D-NMR,CD)分析及衍生物制备,确定Ⅱ为新化合物,即threo-△~7-7-羟基-3,4,5,3′,5′-五甲氧基-8-...自胡椒科胡椒属植物樟叶胡椒(Piper polysyphorum C. DC)中分离到六个新木脂素(neolignans)类化合物,经光谱(UV,IR,MS,~1H-NMR,^(13)C-NMR,2D-NMR,CD)分析及衍生物制备,确定Ⅱ为新化合物,即threo-△~7-7-羟基-3,4,5,3′,5′-五甲氧基-8-O-4′-新木脂素,为一对对映体,命名为樟叶素(polysyphorin),Ⅰ,Ⅲ,Ⅳ为新的对映体,分別为(+)-virolongin,(+)-grandisin及(+)-lancifolin D.化合物Ⅴ为南藤素(wallichinine),Ⅵ为山蒟素D(hancinone D)。血小板活化因子(PAF)受体结合实验及PAF引起的血小板聚集实验证明化合物Ⅰ～Ⅴ具有明显的抑制活性。展开更多
Seven known dibenzocyclooctadiene lignans,tigloylgomisin P(1), angeloylgomisin P(2),gomisin A(3),Schizandrin(4),angeloylgomisin H(5),gomisin B(6) and R(+)-gomisin M_1(7)were isolated from Kadsura heteroclita.The confo...Seven known dibenzocyclooctadiene lignans,tigloylgomisin P(1), angeloylgomisin P(2),gomisin A(3),Schizandrin(4),angeloylgomisin H(5),gomisin B(6) and R(+)-gomisin M_1(7)were isolated from Kadsura heteroclita.The conformation of tiglolylgomisin P(1)was established by 2D NMR techniques.Using[~3H]platelet activating factor(PAF)binding to human platelet membrane assay,(1),(2)and(7)showed PAF receptor antagonistic activities.展开更多
文摘BACKGROUND Sodium-glucose cotransporter 2(SGLT2)inhibitors are widely used for the tr-eatment of type 2 diabetes(T2D).AIM To evaluate the influence of SGLT2 inhibitors on homeostasis model assessment of insulin resistance(HOMA-IR)andβ-cell function(HOMA-β)in patients with T2D in a meta-analysis.METHODS Randomized controlled trials(RCTs)comparing SGLT2 inhibitors to placebo in T2D patients,with a minimum treatment duration of 12 weeks,were searched using the PubMed,EMBASE,and Cochrane Library databases.Risk of bias was assessed using the Cochrane Risk of Bias Tool,and the certainty of evidence was evaluated using the Grading of Recommendations,Assessment,Development and Evaluation(GRADE)system.Changes in HOMA-IR and HOMA-βwere the outcomes analyzed.Meta-analyses were performed using a random-effects model by incorporating the potential influences of heterogeneity.RESULTS Of 1388 articles identified,24 RCTs met the inclusion criteria.23 of the included studies were double-blind RCTs with low risk of bias.Pooled results including 2272 patients showed that SGLT2 inhibitors significantly reduced HOMA-IR compared to placebo[mean difference(MD)=-0.81,95%confidence interval(CI):-1.11 to-0.52,P<0.001;I2=82%],indicating reduced insulin resistance.Addi-tionally,meta-analysis with 2845 patients suggested that SGLT2 inhibitors significantly increased HOMA-β(MD=7.90,95%CI:5.44-10.37,P<0.001;I2=74%)compared to placebo in patients with T2D,indicating improvedβ-cell function.Based on GRADE assessment,the certainty of evidence was rated moderate for both outcomes due to heterogeneity.Subgroup analyses showed that HOMA-βincreased more substantially in non-Asian studies than in Asian studies(P for subgroup difference<0.01).Subgroup analyses according to the individual medications of SGLT2 inhibitors all showed significant improvement of HOMA-IR and HOMA-β(P all<0.05).No significant publication bias was detected(P for Egger’s test all>0.05).CONCLUSION SGLT2 inhibitors are associated with improvements in insulin resistance andβ-cell function in patients with T2D,although the certainty of evidence is moderate due to heterogeneity.
基金supported by Basic Science Research Program through the National Research Foundation(NRF)of Korea,funded by the Ministry of Science and ICT(MSIT),Korea[2022R1A2C2091671]by ITECH R&D Program of MOTIE/KEIT(Ministry of Trade,Industry&Energy/Korea Evaluation Institute of Industrial Technology)[20016808].
文摘Balancing high display performance with energy efficiency is crucial for global sustainability.Lowering operating frequencies—such as enabling 1 Hz operation in fringe-field switching(FFS)liquid crystal displays—reduces power consumption but is hindered by image flicker.While negative dielectric anisotropy liquid crystals(nLCs)mitigate flicker,their high driving voltages and production costs limit adoption.Positive dielectric anisotropy liquid crystals(pLCs)offer lower operating voltages,faster response times,and broader applicability,making them a more viable alternative.This study introduces a novel approach to minimizing flexoelectric effects in pLCs by investigating how single components influence flexoelectric behavior in mixtures through an effective experimental methodology.Two innovative measurement techniques—(1)flexoelectric coefficient difference analysis and(2)displacement-current measurement(DCM)—are presented,marking the first application of DCM for verifying flexoelectric effects.The proposed system eliminates uncertainties associated with previous methods,providing a reliable framework for selecting liquid crystal components with minimal flexoelectric effects while preserving key electro-optic properties.Given pLCs'higher reliability,lower production costs,and broader material selection,these advancements hold significant potential for low-power displays.We believe this work enhances flexoelectric analysis in nematic liquid crystals and contributes to sustainable innovation in the display industry,aligning with global energy-saving goals.
文摘本文系统阐述了经口吸入和鼻用药物制剂(orally inhaled and nasal drug products,OINDPs)生物等效性(bioequivalence,BE)研究评估背景,综述了中国及国际上对该类制剂生物等效性的要求及体外等效性评价指导原则,详细阐述了美国食品药品管理局(FDA)体外生物等效性(in vitro bioequivalence,IVBE)评估的统计学方法和计算公式。采用FDA颁布的布地奈德吸入混悬液指导原则拟定稿中的实例,通过R语言编程途径计算群体生物等效性(population bioequivalence,PBE)统计学参数,并将结果与指导原则中的结果进行对比,提供计算程序的伪代码。本文为OINDPs的研发、质量控制及仿制制剂的开发提供了有益的思路与参考。
基金This project was supported by National Natural Science Foundation of China.
文摘Seven known dibenzocyclooctadiene lignans,tigloylgomisin P(1), angeloylgomisin P(2),gomisin A(3),Schizandrin(4),angeloylgomisin H(5),gomisin B(6) and R(+)-gomisin M_1(7)were isolated from Kadsura heteroclita.The conformation of tiglolylgomisin P(1)was established by 2D NMR techniques.Using[~3H]platelet activating factor(PAF)binding to human platelet membrane assay,(1),(2)and(7)showed PAF receptor antagonistic activities.
